Analysts: Accretive Health Inc (AH)
AH on New York Consolidated
11.10USD
19 Jun 2013
11.10USD
19 Jun 2013
Price Change (% chg)
$-0.04 (-0.36%)
$-0.04 (-0.36%)
Prev Close
$11.14
$11.14
Open
$11.17
$11.17
Day's High
$11.27
$11.27
Day's Low
$11.08
$11.08
Volume
432,399
432,399
Avg. Vol
473,962
473,962
52-wk High
$14.19
$14.19
52-wk Low
$8.55
$8.55
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 0.11 | December | 20 Jun 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 2 | 2 | 2 |
| (2) OUTPERFORM | 2 | 1 | 1 | 1 |
| (3) HOLD | 4 | 4 | 4 | 5 |
| (4) UNDERPERFORM | 1 | 1 | 1 | 1 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.62 | 2.50 | 2.50 | 2.56 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 6 | 253.87 | 261.90 | 242.50 | 270.67 |
| Quarter Ending Sep-13 | 6 | 267.41 | 277.75 | 254.75 | 287.72 |
| Year Ending Dec-13 | 8 | 1,056.10 | 1,095.42 | 1,005.98 | 1,120.88 |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | 6 | 0.11 | 0.13 | 0.09 | 0.15 |
| Quarter Ending Sep-13 | 6 | 0.12 | 0.14 | 0.10 | 0.18 |
| Year Ending Dec-13 | 8 | 0.47 | 0.55 | 0.38 | 0.63 |
| LT Growth Rate (%) | 1 | 30.00 | 30.00 | 30.00 | 24.25 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Sep-12 | 231.18 | 223.13 | 8.04 | 3.48 |
| Quarter Ending Jun-12 | 234.64 | 236.69 | 2.05 | 0.87 |
| Quarter Ending Mar-12 | 231.05 | 253.74 | 22.69 | 9.82 |
| Quarter Ending Dec-11 | 254.27 | 260.08 | 5.81 | 2.29 |
| Quarter Ending Sep-11 | 222.26 | 218.89 | 3.37 | 1.51 |
| Earnings (per share) | ||||
| Quarter Ending Sep-12 | 0.05 | 0.06 | 0.01 | 12.57 |
| Quarter Ending Jun-12 | 0.08 | 0.03 | 0.05 | 60.89 |
| Quarter Ending Mar-12 | 0.06 | 0.06 | 0.00 | 1.69 |
| Quarter Ending Dec-11 | 0.16 | 0.17 | 0.01 | 5.52 |
| Quarter Ending Sep-11 | 0.12 | 0.11 | 0.01 | 9.84 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 253.87 | 253.87 | 254.69 | 253.87 | 270.67 |
| Quarter Ending Sep-13 | 267.41 | 267.41 | 268.76 | 267.41 | 287.72 |
| Year Ending Dec-13 | 1,056.10 | 1,056.10 | 1,060.77 | 1,056.10 | 1,120.88 |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | 0.11 | 0.11 | 0.11 | 0.11 | 0.15 |
| Quarter Ending Sep-13 | 0.12 | 0.12 | 0.12 | 0.12 | 0.18 |
| Quarter Ending Dec-13 | 0.47 | 0.47 | 0.47 | 0.47 | 0.63 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Jun-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates